Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Automation
ROK
|
+$104M |
| 2 |
Bio-Techne
TECH
|
+$79M |
| 3 |
P
Everpure Inc
P
|
+$70.4M |
| 4 |
Fortive
FTV
|
+$61.5M |
| 5 |
JBTM
JBT Marel
JBTM
|
+$59.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Commault Systems
CVLT
|
+$83.5M |
| 2 |
BUFF
Blue Buffalo Pet Products, Inc
BUFF
|
+$79M |
| 3 |
Steris
STE
|
+$66.1M |
| 4 |
WEX
WEX
|
+$57M |
| 5 |
Wabtec
WAB
|
+$43.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.53% |
| 2 | Technology | 17.43% |
| 3 | Industrials | 16.19% |
| 4 | Financials | 14.33% |
| 5 | Consumer Staples | 11.94% |
Similar funds
Champlain Investment Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Champlain Investment Partners held 129 positions worth $10.3B, up 12% from $9.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Champlain Investment Partners deployed $458M of net new capital in Q2 2018, opening 6 new positions and adding to 63 existing holdings. Its largest new stake was Rockwell Automation: 595,645 shares worth $99M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Steris, an estimated $66.1M trimmed.
- Champlain Investment Partners's largest Q2 2018 buy was Rockwell Automation: 595,645 shares worth $99M.
- Champlain Investment Partners added most to Everpure Inc in Q2 2018, an estimated $70.4M increase.
- Champlain Investment Partners's biggest Q2 2018 reduction was Steris, cutting an estimated $66.1M.
- Champlain Investment Partners fully exited Commault Systems in Q2 2018, selling an estimated $83.5M.
- Champlain Investment Partners's ten largest holdings make up 19% of its $10.3B portfolio in Q2 2018.
- Champlain Investment Partners opened 6 new positions and closed 9 in Q2 2018.
- Champlain Investment Partners's portfolio value rose 12% quarter-over-quarter to $10.3B.
Based on Champlain Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.